Now showing items 1-1 of 1

    • SELIMETRY-a multicentre I-131 dosimetry trial: a clinical perspective. 

      Wadsley, J; Gregory, R; Flux, G; Newbold, K; Du, Y; Moss, L; Hall, A; Flanagan, L; Brown, SR (2017-05)
      Treatment options for patients with thyroid cancer that is no longer sensitive to iodine therapy are limited. Those treatments which currently exist are associated with significant toxicity. The SELIMETRY trial (EudraCT ...